Cargando…

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma

Background: Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer. Prior to the advent of immunotherapy, treatment options were limited. In our study, we evaluate the impact of tumor cell PD-L1 expression and tumor immune microenvironment on survival in MCC patients who were not treated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanna, Glenn J., Kacew, Alec J., Tanguturi, Anusha R., Grote, Hans J., Vergara, Victoria, Brunkhorst, Beatrice, Rabinowits, Guilherme, Thakuria, Manisha, LeBoeuf, Nicole R., Ihling, Christian, DeCaprio, James A., Lorch, Jochen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291775/ https://www.ncbi.nlm.nih.gov/pubmed/32582722 http://dx.doi.org/10.3389/fmed.2020.00198

Ejemplares similares

Predictors of immunotherapy benefit in Merkel cell carcinoma
por: Kacew, Alec J., et al.
Publicado: (2020)

Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma
por: Starrett, Gabriel J., et al.
Publicado: (2017)

YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinoma
por: Frost, Thomas C., et al.
Publicado: (2023)

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma
por: Starrett, Gabriel J., et al.
Publicado: (2020)

Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
por: Hanna, Glenn J., et al.
Publicado: (2020)

Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?
por: Rabinowits, Guilherme
Publicado: (2017)

Systemic Therapy for Merkel Cell Carcinoma: What’s on the Horizon?
por: Rabinowits, Guilherme
Publicado: (2014)

Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck
por: Harris, Ethan J., et al.
Publicado: (2020)

Merkel Cell Polyomavirus: Oncogenesis in a Stable Genome
por: Ahmed, Mona M., et al.
Publicado: (2021)

Does a new polyomavirus contribute to Merkel cell carcinoma?
por: Garneski, Kelly M, et al.
Publicado: (2008)

Everolimus in Anaplastic Thyroid Cancer: A Case Series
por: Harris, Ethan J., et al.
Publicado: (2019)

The Merkel Cell Polyomavirus T Antigens Function as Tumor Promoters in Murine Skin
por: Spurgeon, Megan E., et al.
Publicado: (2021)

The biology and treatment of Merkel cell carcinoma: current understanding and research priorities
por: Harms, Paul W., et al.
Publicado: (2018)

Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma
por: Yang, Jiawen, et al.
Publicado: (2023)

Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma
por: Ananthapadmanabhan, Varsha, et al.
Publicado: (2022)

Value and Unmet Needs in Non-Invasive Human Papillomavirus (HPV) Testing for Oropharyngeal Cancer
por: Kacew, Alec J., et al.
Publicado: (2021)

Merkel cell polyomavirus large T antigen binding to pRb promotes skin hyperplasia and tumor development
por: Spurgeon, Megan E., et al.
Publicado: (2022)

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment
por: Morimoto, Yoshihiro, et al.
Publicado: (2022)

An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response
por: Knepper, Todd C., et al.
Publicado: (2021)

Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation
por: Berrios, Christian, et al.
Publicado: (2016)

Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis
por: Park, Donglim Esther, et al.
Publicado: (2020)

Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma
por: Lee, Patrick C., et al.
Publicado: (2022)

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
por: Kaufman, Howard L., et al.
Publicado: (2018)

Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis
por: Cheng, Jingwei, et al.
Publicado: (2017)

RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation
por: Schade, Amy E, et al.
Publicado: (2019)

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
por: Kacew, Alec, et al.
Publicado: (2020)

Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T cell exhaustion in reducing T cell responses
por: Dowlatshahi, Mitra, et al.
Publicado: (2013)

Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks
por: Fischer, Martin, et al.
Publicado: (2016)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma
por: Pietropaolo, Valeria, et al.
Publicado: (2020)

DETECTing Merkel Cell Polyomavirus in Merkel Tumors
por: Arora, Reety, et al.
Publicado: (2020)

Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy
por: Miller, Natalie J., et al.
Publicado: (2018)

RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells
por: Hesbacher, Sonja, et al.
Publicado: (2016)

Characterization of a Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Cell Line CVG-1
por: Velásquez, Celestino, et al.
Publicado: (2018)

Merkel cell carcinoma
por: Mistry, K., et al.
Publicado: (2021)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma, France
por: Foulongne, Vincent, et al.
Publicado: (2008)

Merkel cell polyomavirus and cutaneous Merkel cell carcinoma
por: Minutilli, Ettore, et al.
Publicado: (2016)

Merkel cell polyomavirus and associated Merkel cell carcinoma
por: Yang, June F., et al.
Publicado: (2021)

Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
por: Carter, Joseph J., et al.
Publicado: (2009)

Merkel Cell Polyomavirus T Antigens Induce Merkel Cell-Like Differentiation in GLI1-Expressing Epithelial Cells
por: Kervarrec, Thibault, et al.
Publicado: (2020)

Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2
por: Nomburg, Jason, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l2h0ghhce7dl85fpspb8c34dnc